Vietnam Investment Review on MSN

TriNetX and Regeneron partner on 300 million patient health records

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 3, 2026 /PRNewswire/ -- TriNetX® and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a strategic collaboration to support Regeneron's ...
Pharmabiz

Regeneron collaborates with TriNetX to access de-identified HER of 300 million patients to drive research and product development in life sciences and digital health solutions

Regeneron collaborates with TriNetX to access de-identified HER of 300 million patients to drive research and product development in life sciences and digital health solutions: Ta ...